Viral hepatitis is a liver infection caused by various viruses, including hepatitis A, B, and C, which can lead to inflammation, liver damage, and potentially severe complications. Early detection, vaccination, prevention strategies, and timely treatment are crucial in managing the disease, minimizing the risk of chronic liver conditions, and promoting full recovery.
Viral hepatitis is a liver disease caused by infection with a virus, leading to inflammation and potential long-term liver damage. The most common types—hepatitis A, B, and C—are transmitted through contaminated food, water, or exposure to infected blood and bodily fluids. Hepatitis A typically causes an acute infection and can be prevented with an effective vaccine. Hepatitis B and C, however, can lead to chronic infections, significantly increasing the risk of liver cirrhosis, liver failure, and even liver cancer. Fortunately, a vaccine for hepatitis B is available, offering long-lasting immunity. Although no vaccine currently exists for hepatitis C, antiviral treatments can effectively cure many people with the infection. Early detection, prevention, and treatment are key to managing viral hepatitis and protecting liver health.
Dr. Jack Husney, trained at the Mount Sinai Liver Center, and practicing in New York City, provides expert services for the management of hepatitis, ensuring that most patients can recover completely with prompt and appropriate treatment.